Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apomorphine in Disorders of Consciousness
NCT05213169Phase 3Recruiting
- Sponsor
- University of Liège
- Start
- Jun 2021
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of apomorphine in disorders of consciousness (DoC), sponsored by University of Liège. Started Jun 2021; status: recruiting.
02
Drugs
apomorphine
03
Conditions
disorders of consciousness (DoC)
Beyond the preview
Go deeper on NCT05213169.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05213169.